Vipshop Not Done De...
Health Care: Drugs
Kendle International Inc. (KNDL: NASDAQ)
$15.24 0.00 | 0.03%
07/11/11 - 04:00 PM ET
197.40K / 356.60K
Vol / Avg. Vol:15.24 / 15.23
Open / Prev. Close:15.22 - 15.25
Today's Range:7.68 - 15.25
52 Wk Range:39.90%
Performance YTD:TheStreet Rating:
Portfolios with KNDL
- Portfolio NameUser Type
- UserMicroCap Biotech/Pharma Sto...
- UserMMB
- ContributorBarron's Summary 2-28-2009
- UserPART 2 JPMorgan 27th Annual...
- UserMagnus65 Portfolio 1
- Userdon65 2008 Contest
- Userblackboard
- UserNancy Prial of Essex Invest...
- Usersgilmore Portfolio 1
- UserSUPRATRADE " BUY IT IM...
Latest KNDL Headlines from TheStreet
- Kendle International Inc. Stock Downgraded (KNDL) 03.31.11 | 06:03 pm
- Knot - Upgrades & Downgrades 03.31.11 | 09:03 am
- Stocks Under $10: Healthcare
05.01.09 | 08:05 am - Stocks Under $10: Earnings Season 04.24.09 | 12:04 pm
- Stock Wrap: The Real Story, April 21 04.21.09 | 04:04 pm
- Bank Reversal Ignites Stocks 04.21.09 | 04:04 pm
- Kendle Shares Lose Half Their Value On Cut Outlook 04.21.09 | 12:04 pm
- Kendle Shares Lose Half Their Value On Cut Outlook 04.21.09 | 12:04 pm
- Health Winners & Losers: Kendle 11.05.08 | 04:11 pm
- Health Winners & Losers: Onyx 08.06.08 | 05:08 pm
Press Releases for KNDL
- Kendle International Inc. Announces Expiration Of Tender Offer And Consent Solicitation For Convertible Notes - PR Newswire 07.12.11 | 04:07 pm
- Kendle International Inc. Announces Extension Of Expiration Time Of Tender Offer And Consent Solicitation For Convertible Notes - PR Newswire 07.06.11 | 05:07 pm
- Kendle International Inc. Increases Consideration Amount For Tender Offer And Consent Solicitation For Convertible Notes - PR Newswire 06.17.11 | 08:06 am
- Kendle Experts To Address Key Industry Issues At Drug Information Association 47th Annual Meeting - PR Newswire 06.16.11 | 12:06 pm
- Kendle Appoints Pierre Geoffroy, MD, CM, MSc, FCFP Vice President, Early Stage - PR Newswire 06.07.11 | 09:06 am
- Kendle International Inc. Commences Tender Offer And Consent Solicitation For Convertible Notes - PR Newswire 06.06.11 | 09:06 am
- Kendle Appoints Robert Shepard, MD, FACP Executive Director, Oncology - PR Newswire 06.02.11 | 09:06 am
- Bull & Lifshitz, LLP Announces Investigation Of The Acquisition Of Kendle International Inc. - Business Wire 05.19.11 | 04:05 pm
- The Law Office Of Joseph Klein Is Investigating Possible Breaches Of Fiduciary Duty By The Board Of Kendle International, Inc. In Connection With The Sale Of The Company To INC Research, LLC -- KNDL - Business Wire 05.17.11 | 07:05 pm
- Kendle Rated A "Top CRO To Work With" For Fifth Consecutive Year - PR Newswire 05.12.11 | 09:05 am
Partner Headlines for KNDL
- Company News for May 06, 2011 - Corporate Summary - Zacks 05.06.11 | 10:05 am
- Economic data weigh on Wall Street - Financial Times 05.05.11 | 03:05 pm
- Morning Market Movers (KNDL, EONC, ZSTN, CRU) - Benzinga 05.05.11 | 09:05 am
- Kendle International Reports EPS of $0.03 vs. $0.02; Revenue $77.9M vs. $79.87M - Benzinga 03.02.11 | 04:03 pm
- Kendle Announces Third Quarter EPS of $.10 - Benzinga 11.08.10 | 04:11 pm
- Kendle Announces Second Quarter Results - Benzinga 08.04.10 | 04:08 pm
- CROs Look to Put a Tough 2010 in the Rearview Mirror - SeekingAlpha.com 04.09.10 | 03:04 pm
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.18.10 | 08:03 am
- UPDATE 1-Kendle Q4 profit beats; to cut jobs in Q1 - Reuters 02.24.10 | 06:02 pm
